Event Status
Scheduled
The Targeted Therapeutic Drug Discovery and Development Program (TTP) and Advanced Protein Therapeutics Core (APT) would like to invite you to register for the Lunch and Learn event kindly provided by Revvity on Thursday, August 24, 2023, from 11 a.m. - 1 p.m. in BME 3.204.
This Lunch and Learn will focus on Novel platforms for life science research, from basic science to drug discovery, followed by services available through the TTP and APT core facilities. The Revvity team will present the following subjects:
- Highly sensitive and throughput add-and-read immunoassays: Presented by Grasiella Andriani (Field Applications Scientist) and Ashish Chougule (Product Specialist).
- Multimode plate readers for diverse detection technologies: Presented by Kelsey Oliva (Product Specialist).
- In vivo pre-clinical imaging solutions: Jess Klockow (Field Applications Scientist) and Maurice Weaver (Product Specialist).
Important Notes
- Faculty, research staff, postdocs, graduate students, Pharm.D. students and undergraduates are welcome.
- Revvity will provide free lunch for all registered attendees at the end of the presentation.
- A Q&A session for your inquiries with Revvity specialists will be available at the end of the presentation.
- TTP and APT directors (Drs. Kevin Dalby and Jennifer Maynard) will be on site if you wish to discuss a potential collaboration.
Please contact euncho@austin.utexas.edu, annalee@utexas.edu or ashish.chougule@revvity.com if you have any questions.
Revvity (previously affiliated with PerkinElmer, Inc.) is a visionary partner in developing technologies and solutions to help solve the world’s most significant health challenges. Revvity offers various technologies and instrumentation, such as drug discovery reagents, microplate readers, in vivo imaging etc., for different life sciences research fields. You can sign in here to find brochures, flyers and application notes for these other technologies.
Event Details
Date and Time
-
Location
Austin